home / stock / phar / phar news


PHAR News and Press, Pharming Group N.V. From 05/16/25

Stock Information

Company Name: Pharming Group N.V.
Stock Symbol: PHAR
Market: NASDAQ
Website: pharming.com

Menu

PHAR PHAR Quote PHAR Short PHAR News PHAR Articles PHAR Message Board
Get PHAR Alerts

News, Short Squeeze, Breakout and More Instantly...

PHAR - How To Trade (PHAR)

2025-05-16 15:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PHAR - Pharming GAAP EPS of -$0.02 beats by $0.01, revenue of $79.09M beats by $15.15M

2025-05-09 09:35:20 ET More on Pharming Pharming Group N.V. 2025 Q1 - Results - Earnings Call Presentation Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript Pharming Group: Small Dutch Company With Strong Revenues Pharming Group outlines 2025 revenu...

PHAR - Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript

2025-05-09 08:50:38 ET Pharming Group N.V. (PHAR) Q1 2025 Earnings Conference Call May 08, 2025, 07:30 AM ET Company Participants Fabrice Chouraqui – CEO Stephen Toor – CCO Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Confer...

PHAR - Expected US Company Earnings on Thursday, May 8th, 2025

Ironwood Pharmaceuticals Inc. (IRWD) is expected to report $-0.05 for Q1 2025 CaliberCos Inc. (CWD) is expected to report $-0.4 for Q1 2025 BlackRock TCP Capital Corp. (TCPC) is expected to report $0.34 for Q1 2025 INmune Bio Inc. (INMB) is expected to report $-0.43 for Q1 2025 No...

PHAR - Objective long/short (PHAR) Report

2025-04-04 14:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

PHAR - Pharming Group: Small Dutch Company With Strong Revenues

2025-04-01 08:45:40 ET Summary Pharming Group, a Dutch biotech firm, excels with RUCONEST and JOENJA, showing strong revenue growth and positive cash flow despite low US trading volume. RUCONEST and JOENJA drive revenue, with RUCONEST contributing $252.2M and JOENJA surging 147% t...

PHAR - Pharming Group outlines 2025 revenue guidance of $315M to $335M driven by RUCONEST and Joenja growth

2025-03-13 19:45:04 ET More on Pharming, Pharming Group N.V., etc. Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript Pharming Group appoints former Novartis USA President Fabrice Chouraqui as New CEO Pharming Group offers to buy Sweden's Abliva for SEK 0.45...

PHAR - Pharming Group N.V. (PHAR) Q4 2024 Earnings Call Transcript

2025-03-13 19:44:30 ET Pharming Group N.V. (PHAR) Q4 2024 Earnings Conference Call March 13, 2025, 8:30 a.m. ET Company Participants Fabrice Chouraqui - CEO Stephen Toor - CCO Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call P...

PHAR - Expected US Company Earnings on Thursday, March 13th, 2025

Team Inc. (TISI) is expected to report for quarter end 2024-12-31 Chesswood Group Limited (CHWWQ) is expected to report for Q4 2024 J. W. Mays Inc. (MAYS) is expected to report for Q2 2025 Allakos Inc. (ALLK) is expected to report $-0.17 for Q4 2024 Aurora Mobile Limited (JG) is e...

PHAR - (PHAR) Technical Data

2025-02-21 14:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Previous 10 Next 10